Drug information for FIRMAGON

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
POWDER; SUBCUTANEOUS EQ 120MG BASE/VIAL Prescription  (Reference Drug) DEGARELIX ACETATE acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide FERRING 22201
2009-02-17 Review

2009-02-17 Summary Review

2008-12-30 Letter

2008-12-29 Label
POWDER; SUBCUTANEOUS EQ 80MG BASE/VIAL Prescription   DEGARELIX ACETATE acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide FERRING   "

Drug Adverse Effects information for FIRMAGON

Role code Indications Reaction # Reports
PS PRODUCT USED FOR UNKNOWN INDICATION ABDOMINAL PAIN 1
PS PRODUCT USED FOR UNKNOWN INDICATION DISEASE PROGRESSION 1
PS PRODUCT USED FOR UNKNOWN INDICATION DRUG INEFFECTIVE 1
PS PRODUCT USED FOR UNKNOWN INDICATION HEADACHE 1
PS PRODUCT USED FOR UNKNOWN INDICATION HYPERTENSION 1
PS PRODUCT USED FOR UNKNOWN INDICATION INJECTION SITE PAIN 1
PS PRODUCT USED FOR UNKNOWN INDICATION MYALGIA 1
PS PRODUCT USED FOR UNKNOWN INDICATION OEDEMA PERIPHERAL 1
PS PRODUCT USED FOR UNKNOWN INDICATION OVERDOSE 1
PS PRODUCT USED FOR UNKNOWN INDICATION PYREXIA 1
PS PRODUCT USED FOR UNKNOWN INDICATION TONGUE DISORDER 1
PS PRODUCT USED FOR UNKNOWN INDICATION TRANSURETHRAL PROSTATECTOMY 2
PS PRODUCT USED FOR UNKNOWN INDICATION UNEVALUABLE EVENT 1
PS PROSTATE CANCER ABDOMINAL PAIN 2
PS PROSTATE CANCER ASTHENIA 2
PS PROSTATE CANCER BACK PAIN 2
PS PROSTATE CANCER BREAST PAIN 1
PS PROSTATE CANCER BREAST SWELLING 1
PS PROSTATE CANCER CARDIAC DEATH 1
PS PROSTATE CANCER CARDIAC DISORDER 1
PS PROSTATE CANCER CONFUSIONAL STATE 2
PS PROSTATE CANCER DEATH 2
PS PROSTATE CANCER DEPRESSION 2
PS PROSTATE CANCER DIARRHOEA 2
PS PROSTATE CANCER DIZZINESS 2
PS PROSTATE CANCER DYSPNOEA EXERTIONAL 1
PS PROSTATE CANCER EATING DISORDER 1
PS PROSTATE CANCER FATIGUE 5
PS PROSTATE CANCER FLUSHING 1
PS PROSTATE CANCER HAEMATOCRIT DECREASED 1
PS PROSTATE CANCER HAEMOGLOBIN DECREASED 1
PS PROSTATE CANCER HEADACHE 2
PS PROSTATE CANCER HOT FLUSH 2
PS PROSTATE CANCER HYPOAESTHESIA 1
PS PROSTATE CANCER HYPOTENSION 1
PS PROSTATE CANCER INJECTION SITE DISCOLOURATION 1
PS PROSTATE CANCER INJECTION SITE ERYTHEMA 3
PS PROSTATE CANCER INJECTION SITE NODULE 3
PS PROSTATE CANCER INJECTION SITE PAIN 2
PS PROSTATE CANCER INTERSTITIAL LUNG DISEASE 1
PS PROSTATE CANCER METASTASES TO BONE 1
PS PROSTATE CANCER MICTURITION URGENCY 1
PS PROSTATE CANCER NAUSEA 1
PS PROSTATE CANCER NOCTURIA 1
PS PROSTATE CANCER PALPITATIONS 1
PS PROSTATE CANCER PARAESTHESIA 1
PS PROSTATE CANCER PNEUMONIA 1
PS PROSTATE CANCER POLLAKIURIA 2
PS PROSTATE CANCER QUALITY OF LIFE DECREASED 2
PS PROSTATE CANCER RENAL FAILURE 1
PS PROSTATE CANCER TESTICULAR ATROPHY 2
PS PROSTATE CANCER METASTATIC INTERSTITIAL LUNG DISEASE 1
C PRODUCT USED FOR UNKNOWN INDICATION ACUTE MYELOID LEUKAEMIA 6
C PRODUCT USED FOR UNKNOWN INDICATION MYELODYSPLASTIC SYNDROME 6
C PRODUCT USED FOR UNKNOWN INDICATION PANCYTOPENIA 6
C PRODUCT USED FOR UNKNOWN INDICATION PULMONARY EMBOLISM 6
C PRODUCT USED FOR UNKNOWN INDICATION THROMBOCYTOPENIA 6
C PROPHYLAXIS ACUTE MYELOID LEUKAEMIA 2
C PROPHYLAXIS MYELODYSPLASTIC SYNDROME 2
C PROPHYLAXIS PANCYTOPENIA 2
C PROPHYLAXIS PULMONARY EMBOLISM 2
C PROPHYLAXIS THROMBOCYTOPENIA 2
C PROSTATE CANCER METASTATIC ACUTE MYELOID LEUKAEMIA 4
C PROSTATE CANCER METASTATIC LONG QT SYNDROME 1
C PROSTATE CANCER METASTATIC MYELODYSPLASTIC SYNDROME 4
C PROSTATE CANCER METASTATIC PANCYTOPENIA 4
C PROSTATE CANCER METASTATIC PULMONARY EMBOLISM 4
C PROSTATE CANCER METASTATIC PULMONARY OEDEMA 1
C PROSTATE CANCER METASTATIC THROMBOCYTOPENIA 4
C PULMONARY EMBOLISM ACUTE MYELOID LEUKAEMIA 2
C PULMONARY EMBOLISM MYELODYSPLASTIC SYNDROME 2
C PULMONARY EMBOLISM PANCYTOPENIA 2
C PULMONARY EMBOLISM PULMONARY EMBOLISM 2
C PULMONARY EMBOLISM THROMBOCYTOPENIA 2
Ads by Google